A5039205229- Blood Pressure and Hypertension Studies
- Pelvic floor disorders treatments
- Hemodynamic Monitoring and Therapy
- Telemedicine and Telehealth Implementation
- Diet and metabolism studies
- Cardiac Health and Mental Health
- Cardiovascular Health and Disease Prevention
- Non-Invasive Vital Sign Monitoring
- Heart Rate Variability and Autonomic Control
- Nonprofit Sector and Volunteering
- Peroxisome Proliferator-Activated Receptors
- Cardiac Ischemia and Reperfusion
- Organ and Tissue Transplantation Research
- Inflammatory mediators and NSAID effects
- Cardiovascular Function and Risk Factors
- Cardiovascular Disease and Adiposity
- Urinary Tract Infections Management
- COVID-19 and healthcare impacts
- Fatty Acid Research and Health
- Mobile Health and mHealth Applications
- Hormonal Regulation and Hypertension
- Prenatal Screening and Diagnostics
- Bone fractures and treatments
- Nutrition and Health in Aging
- Sport and Mega-Event Impacts
Saint John Regional Hospital
2014-2022
Dalhousie University
2019-2021
University of Southern California
2021
Horizon Health Network
2020-2021
University of Northampton
2019
Charles River Laboratories (United Kingdom)
2010
Lawson Health Research Institute
2006
University of Aberdeen
1989
Chinese University of Hong Kong
1988
During the COVID-19 pandemic, telemedicine has emerged worldwide as an indispensable resource to improve surveillance of patients, curb spread disease, facilitate timely identification and management ill people, but, most importantly, guarantee continuity care frail patients with multiple chronic diseases. Although during thrived, its adoption moved forward in many countries, important gaps still remain. Major issues be addressed enable large scale implementation include: (1) establishing...
This Clinical Update summarizes the main approaches to out-of-office blood pressure monitoring—home monitoring and ambulatory benefits challenges of each in management hypertension.
Background: Clinical guidelines recommend monitoring of blood pressure at home using an automatic device for the management hypertension. Devices are not often calibrated against direct measures, leaving health care providers and patients with less reliable information than is possible current technology. Rigorous assessments medical devices necessary establishing clinical utility. Objective: The purpose our study was 2-fold: (1) to assess validity perform iterative calibration indirect...
Introduction Increasing levels of obesity worldwide have led to a rise in the prevalence obesity-related complications including cardiovascular risk factors such as diabetes, hypertension and dyslipidaemia. Healthcare providers believe that overweight obese cardiac surgery patients are more likely experience adverse postoperative outcomes. The body mass index (BMI) is primary measure clinical practice, without accounting for patient’s level cardiopulmonary fitness or muscle mass. objective...
Monitoring Blood Pressure Outside of the Doctor's OfficeIf your blood pressure is suspected to be high, it important know measurement pattern outside doctor's office.
Abstract Canada is a wealthy nation with geographically diverse population, seeking health innovations to better serve patients in accordance the Health Act. In this country, population and geography converge social determinants, policy, procurement regulations, technological advances, order achieve equity management distribution of healthcare. Rural remote are vulnerable population; when managing chronic conditions such as cardiovascular disease, there inequity it comes accessing specialist...
Over the past year, amyotrophic lateral sclerosis (ALS) associations have benefitted from people embracing “ice bucket challenge,” in which cold water is tipped over participant’s head. To date, about 150 million dollars has been donated worldwide as a result of challenge. However
An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the ‘Save PDF’ action button.
It is generally accepted that induction of iNOS, but not eNOS, in the heart renders it less susceptible to detrimental effects an ischemia/reperfusion (I/R) challenge. However, there some evidence indicate eNOS (adenosine receptor agonist) can also provide protection against I/R-induced myocardial dysfunction and injury. We have recently shown pretreatment with erythropoietin (EPO) ameliorate inflammation associated I/R challenge given 24 hrs later. The aim present study was determine...